Off Patent March 2027
Veletri
epoprostenol sodium
Actelion Pharmaceuticals US Inc
Injectable (injection) · NDA 022260
Last listed protection ends
March 15, 2027
The FDA lists 2 patents for Veletri, and this is the day the last one ends. It is not the date a generic goes on sale.
Patents and exclusivities
- Patent 8,598,227No claim type listed
- Patent 8,318,802Claims the drug product